Questions and answers published after July 2012 can be viewed here. Viewing by Government Department is possible by term or specific dates from March 2016 onwards. Written answers are published as received from departments. To see parliamentary questions published before July 2012, search in Dáil debates.
Questions and answers for Dáil or Seanad term
Page 82 of 148
Wed, 13 Jul 2022
written
Medicinal Products
Colm Burke
72. Deputy Colm Burke asked the Tánaiste and Minister for Enterprise, Trade and Employment if the adoption of a strong pro-innovation position in relation to the European Pharmaceutical Strategy has the potential to protect existing jobs, create new jobs and further help new treatments to originate and be developed in Ireland and Europe; and if he will make a statement on the matter. [38311/22]
Wed, 13 Jul 2022
written
Medicinal Products
Colm Burke
73. Deputy Colm Burke asked the Tánaiste and Minister for Enterprise, Trade and Employment his views on whether there is a role for Ireland, along with other economically advanced, similar-sized countries, in supporting the protection of innovation in the European Union Pharmaceutical Strategy in order that Ireland remains competitive for new investments and raise standards of care; and if he will make a statement on the matter. [38313/22]
Wed, 13 Jul 2022
written
Defence Forces
Colm Burke
290. Deputy Colm Burke asked the Minister for Defence if it is intended that new direct entry medical officers in the Defence Forces will be entered into the specialist division in general practice; and if he will make a statement on the matter. [38257/22]
Wed, 13 Jul 2022
written
Defence Forces
Colm Burke
291. Deputy Colm Burke asked the Minister for Defence if the military medicine training scheme to induct new medical practitioner trainees will be advertised in 2022 and if whatever barriers and issues which prevented such intake in 2021 will be removed and resolved; and if he will make a statement on the matter. [38258/22]
Wed, 13 Jul 2022
written
Research and Development
Colm Burke
437. Deputy Colm Burke asked the Minister for Further and Higher Education, Research, Innovation and Science if his Department has engaged with officials from the Department of Health in relation to the European Union Pharmaceutical Strategy; and if he will make a statement on the matter. [38793/22]
Wed, 13 Jul 2022
written
Intellectual Property
Colm Burke
438. Deputy Colm Burke asked the Minister for Further and Higher Education, Research, Innovation and Science the level of engagement that his Department has had to date with the Department of Enterprise, Trade and Employment in relation to the protection of intellectual property rights within the research and development and innovation sectors; and if he will make a statement on the matter. [38794/22]
Wed, 13 Jul 2022
written
Intellectual Property
Colm Burke
439. Deputy Colm Burke asked the Minister for Further and Higher Education, Research, Innovation and Science his views on whether intellectual property rights should be protected especially in the development of innovative medicinal products; and if he will make a statement on the matter. [38795/22]
Wed, 13 Jul 2022
written
Intellectual Property
Colm Burke
440. Deputy Colm Burke asked the Minister for Further and Higher Education, Research, Innovation and Science the level of interaction that he has had with industry representatives about trade-related intellectual property rights; and if he will make a statement on the matter. [38796/22]
Wed, 13 Jul 2022
written
Medicinal Products
Colm Burke
454. Deputy Colm Burke asked the Minister for Health if his Department’s white paper on Enterprise Policy will be taken into account as part of Ireland’s position in respect of the European Union Pharmaceutical Strategy; and if he will make a statement on the matter. [38312/22]
Wed, 13 Jul 2022
written
Medicinal Products
Colm Burke
456. Deputy Colm Burke asked the Minister for Health if he has engaged with the Department of Taoiseach and the Department of Enterprise, Trade and Employment in relation to formulating a Government position on the European Union Pharmaceutical Strategy. [38786/22]
Wed, 13 Jul 2022
written
Medicinal Products
Colm Burke
457. Deputy Colm Burke asked the Minister for Health if he intends to set up a cross-Departmental working group to consider the European Union Pharmaceutical Strategy and its implications for biopharmaceutical innovation in Ireland. [38787/22]
Wed, 13 Jul 2022
written
Covid-19 Pandemic
Colm Burke
478. Deputy Colm Burke asked the Minister for Health if he will outline in detail the plans that his Department has to implement guidelines and structures to support general practitioners in assisting patients with long-Covid to ensure that they receive appropriate care; and if he will make a statement on the matter. [38259/22]
Wed, 13 Jul 2022
written
Covid-19 Pandemic
Colm Burke
479. Deputy Colm Burke asked the Minister for Health if he will outline in detail the way that his Department plans to ensure the Model of Care plan published in September 2021 is fully implemented in all chosen sites; if consideration will be given to updating the plan to reflect the emerging knowledge of the neurological nature of the condition; and if he will make a statement on the matter. [38260/22]
Wed, 13 Jul 2022
written
Medicinal Products
Colm Burke
500. Deputy Colm Burke asked the Minister for Health if he intends to set up a cross-Departmental working group to consider the European Union Pharmaceutical Strategy; and if he will make a statement on the matter. [38282/22]
Wed, 13 Jul 2022
written
Medicinal Products
Colm Burke
501. Deputy Colm Burke asked the Minister for Health if he intends to launch a public consultation for industry and interested stakeholders to assist in developing Ireland’s position in relation to the European Union Pharmaceutical Strategy; and if he will make a statement on the matter. [38283/22]
Wed, 13 Jul 2022
written
Intellectual Property
Colm Burke
502. Deputy Colm Burke asked the Minister for Health his views on whether medicines pricing and intellectual property rights are unrelated, with pricing determined by national governments through industry negotiations and intellectual property rights set through international trade agreements as incentives for innovation; and if he will make a statement on the matter. [38284/22]
Wed, 13 Jul 2022
written
Medicinal Products
Colm Burke
503. Deputy Colm Burke asked the Minister for Health his views on whether the European Union Pharmaceutical Strategy could place at risk certain intellectual property rights, including those for orphan and paediatric medicines; if such a move could damage jobs, competitiveness and the development of new medicines; and if he will make a statement on the matter. [38285/22]
Wed, 13 Jul 2022
written
Medicinal Products
Colm Burke
504. Deputy Colm Burke asked the Minister for Health his views on whether a proposal by an organisation (details supplied) on equity-based tiered pricing would help to broaden access to new medicines for all Europe’s citizens; and if he will make a statement on the matter. [38286/22]
Wed, 13 Jul 2022
written
Medicinal Products
Colm Burke
505. Deputy Colm Burke asked the Minister for Health his views on whether there is a role for Ireland, along with other economically advanced, similar-sized countries in supporting the protection of innovation in the European Union Pharmaceutical Strategy in order that Ireland remains competitive for new investments and raise standards of care; and if he will make a statement on the matter. [38287/22]
Wed, 13 Jul 2022
written
Medicinal Products
Colm Burke
506. Deputy Colm Burke asked the Minister for Health if he intends to increase his Department’s representation in Brussels to ensure Ireland’s position is adequately represented in European Council negotiations; and if he will make a statement on the matter. [38288/22]